Nephrostomy Device Market Size, Share, Growth Analysis, By End Use(Hospitals, Emergency Clinics, Ambulatory Centers (ASCs).), By Product(Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2633 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 64 |Figures: 77

Nephrostomy Device Market Insights

Nephrostomy Device Market size was valued at USD 1.27 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.67 billion by 2031, at a CAGR of 8.6% during the forecast period (2024-2031)

The nephrostomy devices market is being driven by various factors such as the growing prevalence of kidney stone disorder, a rising demand for minimally invasive surgical procedures, and increased awareness about these devices.

According to a study published in the National Center for Biotechnology Information (NCBI), urolithiasis affects approximately 12% of the global population. Additionally, the American Cancer Society predicts that there will be around 81,800 new cases of kidney cancer in the United States in 2023, further highlighting the high prevalence of kidney diseases.

The increasing incidence of kidney diseases, including cancer, creates a greater demand for nephrostomy devices. Individuals with cancer may require a nephrostomy if there is a blockage in their urinary system. This drives the market growth as the need for these devices increases. The demand for minimally invasive surgeries (MIS) is another significant factor contributing to the market's growth.

Compared to open surgery, minimally invasive surgery offers numerous advantages, such as shorter hospital stays, reduced blood loss, lower postoperative complications, less operative pain, improved cosmetic outcomes, and equivalent oncological results. These benefits drive the demand for nephrostomy devices, as they are commonly used in MIS procedures.

While the market has positive growth prospects, there are some challenges that may hinder its progress. Alternative procedures and the associated risks related to nephrostomy present potential obstacles to market growth. It is important to consider these factors when evaluating the overall market dynamics.

US Nephrostomy Device Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 1.17 billion

Largest Segment

Hospitals

Fastest Growth

Hospitals

Growth Rate

8.6% CAGR

Global Nephrostomy Device Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Nephrostomy Device Market Segmental Analysis

The global nephrostomy device market is segmented on the product, end-use and region. By product, the market is segmented into guidewires, drainage tubes, nephrostomy catheters, sheath dilators. By end use, the market is segmented into hospitals, emergency clinics, ambulatory centers (ASCs). By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Nephrostomy Device Market Analysis by Product

The dominant segment in the global nephrostomy devices market is the guidewires segment. This is due to the increasing use of guidewires in percutaneous nephrolithotomy (PCNL) procedures. It is a minimally invasive procedure used to remove kidney stones. Guidewires are used to guide the nephroscope, a small camera that is inserted into the kidney, to the site of the kidney stone.

The fastest growing segment in the global nephrostomy devices market is the nephrostomy catheters segment. This is due to the increasing use of nephrostomy catheters in the treatment of kidney infections and other conditions that require drainage of the kidney. Nephrostomy catheters are small tubes that are inserted into the kidney to drain urine.

Nephrostomy Device Market Analysis by End Use

The hospitals segment is the largest end-user of nephrostomy devices, accounting for a share of over 60% in 2022. This is due to the fact that hospitals are the primary settings for the diagnosis and treatment of kidney stones and other urological conditions.

The fastest CAGR is likely to be seen in ambulatory surgical centers (ASCs), as they provide more individualized care. Additionally, the better results compared to hospitals and other healthcare settings are another factor propelling the industry. The segment growth is further aided by the fact that ASCs have half as many infection risks during surgery as hospitals do. Additionally, since ASCs are not challenged with treating a variety of illnesses and disorders, they can guarantee that patients receive personalized care and an improved patient experience.

Global Nephrostomy Device Market By End Use

To get detailed analysis on other segments, Request For Free Sample Report

Nephrostomy Device Market Regional Insights

North America has been the leading market in the past and is projected to continue witnessing substantial growth in the future. This can be attributed to favorable reimbursement policies, growing awareness about these products, the presence of highly skilled physicians, and well-established healthcare facilities in the region. Additionally, the region's quick adoption of technologically advanced medical products is expected to drive market growth. Increased government funding for research and development activities related to surgical devices and procedures is also positively impacting the market in North America.

Asia Pacific is anticipated to achieve growth rate (CAGR) from 2019 to 2026. This growth can be attributed to the rising prevalence of kidney disorders, positive government initiatives, and awareness programs conducted by non-governmental organizations (NGOs) to educate the population about these products. The presence of numerous key companies in China and India also contributes to market growth in the region. Furthermore, the rapidly expanding medical tourism market in emerging economies of Asia Pacific is expected to drive the demand for ambulatory surgical centers, thereby fostering market growth

Global Nephrostomy Device Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Nephrostomy Device Market Dynamics

Nephrostomy Device Market Drivers

Technological Advancements

  • Advancements in nephrostomy devices, such as improved catheter materials, better imaging techniques for guidance, and enhanced drainage systems, have increased the effectiveness and safety of nephrostomy procedures. These technological advancements drive market growth as healthcare providers seek to adopt more advanced and efficient devices.
  • Nephrostomy procedures are considered minimally invasive, as they involve accessing the kidney through a small incision or puncture. The growing preference for minimally invasive procedures among patients and healthcare providers contributes to the market growth of nephrostomy devices.

Nephrostomy Device Market Restraints

High Cost of Devices

  • The cost of nephrostomy devices can be relatively high, which can limit their adoption in certain healthcare settings and regions. The cost includes not only the devices themselves but also the associated consumables and accessories required for the procedure. The high cost can pose a challenge for healthcare facilities with limited budgets or for patients who may have financial constraints.

Request Free Customization of this report to help us to meet your business objectives.

Nephrostomy Device Market Competitive Landscape

The competitive landscape of the nephrostomy devices market encompasses various details about individual competitors operating within the market. These details include company overviews, financial information, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites and facilities, production capacities, strengths and weaknesses of the company, product launches, product range, and dominant applications. It is important to note that these data points specifically pertain to the companies' activities and focus within the nephrostomy devices market.

Nephrostomy Device Market Top Player’s Company Profiles

  • C. R. Bard, Inc. (United States)
  • Medtronic plc (Ireland)
  • Teleflex Incorporated (United States)
  • BD (Becton, Dickinson and Company) (United States)
  • Coloplast Group (Denmark)
  • ROCAMED (France)
  • UROMED Kurt Drews KG (Germany)
  • Argon Medical Devices (United States)
  • Eurovision GmbH (Germany)
  • Amecath (Spain)
  • SURGIMEDIK (Turkey)
  • Envaste Medical (United States)
  • TROGE MEDICAL GmbH (Germany)
  • Porges SA (Argentina)
  • Well Lead Medical Co., Ltd. (China)
  • Surgitech (India)
  • Allium Medical Solutions Ltd. (Israel)
  • Stryker Corporation (United States)
  • Zimmer Biomet (United States)

Nephrostomy Device Market Recent Developments

  • In April 2023, Teleflex Medical announced the launch of its new Arrow Guard nephrostomy catheter. The catheter is designed to be more secure and less likely to come out of place, which can help to reduce the risk of complications.
  • In March 2023, Bard Access Systems received FDA approval for its new Bard FlexRoute nephrostomy catheter. The catheter is designed to be more flexible and easier to navigate, which can help to improve the success rate of percutaneous nephrostomy procedures.
  • In February 2023, Cook Medical announced the launch of its new Flexoma Ergo nephrostomy catheter. The catheter is designed to be more flexible and easier to insert, which can help to reduce the risk of complications.

Nephrostomy Device Key Market Trends

Increasing Preference for Disposable Devices

  • There is a growing preference for disposable nephrostomy devices over reusable ones. Disposable devices offer advantages such as reduced risk of cross-contamination and infection transmission, ease of use, and convenience. Healthcare facilities are increasingly adopting disposable devices to improve patient safety and minimize the need for reprocessing and sterilization

Nephrostomy Device Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the nephrostomy devices market has been experiencing steady growth and is expected to continue growing in the coming years. Factors such as the rising prevalence of kidney disorders, increasing geriatric population, and advancements in healthcare infrastructure contribute to market growth. Additionally, the growing demand for minimally invasive procedures and the preference for nephrostomy over more invasive surgical interventions further drive market expansion. The nephrostomy devices market presents opportunities for growth due to increasing incidences of kidney disorders, technological advancements, and the rising demand for minimally invasive procedures. However, addressing challenges and ensuring cost-effectiveness, accessibility, and patient safety will be crucial for sustained market growth.

Report Metric Details
Market size value in 2022 USD 1.27 billion
Market size value in 2031 USD 2.67 billion
Growth Rate 8.6%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • End Use
    • Hospitals, Emergency Clinics, Ambulatory Centers (ASCs).
  • Product
    • Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • C. R. Bard, Inc. (United States)
  • Medtronic plc (Ireland)
  • Teleflex Incorporated (United States)
  • BD (Becton, Dickinson and Company) (United States)
  • Coloplast Group (Denmark)
  • ROCAMED (France)
  • UROMED Kurt Drews KG (Germany)
  • Argon Medical Devices (United States)
  • Eurovision GmbH (Germany)
  • Amecath (Spain)
  • SURGIMEDIK (Turkey)
  • Envaste Medical (United States)
  • TROGE MEDICAL GmbH (Germany)
  • Porges SA (Argentina)
  • Well Lead Medical Co., Ltd. (China)
  • Surgitech (India)
  • Allium Medical Solutions Ltd. (Israel)
  • Stryker Corporation (United States)
  • Zimmer Biomet (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Nephrostomy Device Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Nephrostomy Device Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Nephrostomy Device Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Nephrostomy Device Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Nephrostomy Device Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Nephrostomy Device Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Nephrostomy Device Market size was valued at USD 1.27 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.67 billion by 2031, at a CAGR of 8.6% during the forecast period (2024-2031)

The competitive landscape of the nephrostomy devices market encompasses various details about individual competitors operating within the market. These details include company overviews, financial information, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites and facilities, production capacities, strengths and weaknesses of the company, product launches, product range, and dominant applications. It is important to note that these data points specifically pertain to the companies' activities and focus within the nephrostomy devices market. 'Boston Scientific Corporation (United States)', 'Cook Medical Incorporated (United States)', 'Olympus Corporation (Japan)', 'C. R. Bard, Inc. (United States)', 'Medtronic plc (Ireland)', 'Teleflex Incorporated (United States)', 'BD (Becton, Dickinson and Company) (United States)', 'Coloplast Group (Denmark)', 'ROCAMED (France)', 'UROMED Kurt Drews KG (Germany)', 'Argon Medical Devices (United States)', 'Eurovision GmbH (Germany)', 'Amecath (Spain)', 'SURGIMEDIK (Turkey)', 'Envaste Medical (United States)', 'TROGE MEDICAL GmbH (Germany)', 'Porges SA (Argentina)', 'Well Lead Medical Co., Ltd. (China)', 'Surgitech (India)', 'Allium Medical Solutions Ltd. (Israel)', 'Stryker Corporation (United States)', 'Zimmer Biomet (United States)'

Advancements in nephrostomy devices, such as improved catheter materials, better imaging techniques for guidance, and enhanced drainage systems, have increased the effectiveness and safety of nephrostomy procedures. These technological advancements drive market growth as healthcare providers seek to adopt more advanced and efficient devices.

There is a growing preference for disposable nephrostomy devices over reusable ones. Disposable devices offer advantages such as reduced risk of cross-contamination and infection transmission, ease of use, and convenience. Healthcare facilities are increasingly adopting disposable devices to improve patient safety and minimize the need for reprocessing and sterilization

North America has been the leading market in the past and is projected to continue witnessing substantial growth in the future. This can be attributed to favorable reimbursement policies, growing awareness about these products, the presence of highly skilled physicians, and well-established healthcare facilities in the region. Additionally, the region's quick adoption of technologically advanced medical products is expected to drive market growth. Increased government funding for research and development activities related to surgical devices and procedures is also positively impacting the market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35A2633

$5,300
BUY NOW GET FREE SAMPLE